Nataša Anastasov

Dr. Nataša Anastasov

Helmholtz Center Munich
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 December 2019 in ACS Central Science
Verified
Journal Article
Open access
VKVanessa A. N. Kraft
Vanessa A. N. Kraft
CBCarla T. Bezjian
Carla T. Bezjian
SPSusanne Pfeiffer
Susanne Pfeiffer
LRLarissa Ringelstetter
Larissa Ringelstetter
CMConstanze Müller
Constanze Müller
JSJoel Schick
Joel Schick
Ferroptosis is an iron-dependent form of regulated cell death linking iron, lipid, and glutathione levels to degenerative processes and tumor suppression. By performing a genome-wide activation screen, we identified a cohort of genes antagonizing ferroptotic cell death, including GTP cyclohydrolase-1 (GCH1) and its metabolic derivatives tetrahydrobiopterin/dihydrobiopterin (BH4/BH2). Synthesis of BH4/BH2 by GCH1-expressing cells caused lipid remodeling, suppressing ferroptosis by selectively preventing depletion of phospholipids with two polyunsaturated fatty acyl tails. GCH1 expression level in cancer cell lines stratified susceptibility to ferroptosis, in accordance with its expression in human tumor samples. The GCH1-BH4-phospholipid axis acts as a master regulator of ferroptosis resistance, controlling endogenous production of the antioxidant BH4, abundance of CoQ10, and peroxidation of unusual phospholipids with two polyunsaturated fatty acyl tails. This demonstrates a unique mechanism of ferroptosis protection that is independent of the GPX4/glutathione system.

20 January 2014 in Oncotarget
Verified
Journal Article
Open access
PDF file
ULUlrike M. Litzenburger
Ulrike M. Litzenburger
COChristiane A. Opitz
Christiane A. Opitz
FSFelix Sahm
Felix Sahm
KRKatharina J. Rauschenbach
Katharina J. Rauschenbach
STSaskia Trump
Saskia Trump
MPMichael Platten
Michael Platten
Indoleamine-2,3-dioxygenase (IDO) inhibitors have entered clinical trials based on their ability to restore anti-tumor immunity in preclinical studies. However, the mechanisms leading to constitutive expression of IDO in human tumors are largely unknown. Here we analyzed the pathways mediating constitutive IDO expression in human cancer. IDO-positive tumor cells and tissues showed basal phosphorylation and acetylation of STAT3 as evidenced by western blotting and immunoprecipitation. Inhibition of IL-6 or STAT3 using siRNA and/or pharmacological inhibitors reduced IDO mRNA and protein expression as well as kynurenine formation. In turn, IDO enzymatic activity activated the AHR as shown by the induction of AHR target genes. IDO-mediated AHR activation induced IL-6 expression, while inhibition or knockdown of the AHR reduced IL-6 expression. IDO activity thus sustains its own expression via an autocrine AHR–IL-6–STAT3 signaling loop. Inhibition of the AHR–IL-6–STAT3 signaling loop restored T-cell proliferation in mixed leukocyte reactions performed in the presence of IDO-expressing human cancer cells. Identification of the IDO-AHR-IL-6-STAT3 signaling loop maintaining IDO expression in human cancers reveals novel therapeutic targets for the inhibition of this core pathway promoting immunosuppression of human cancers. The relevance of the IDO-AHR-IL-6-STAT3 transcriptional circuit is underscored by the finding that high expression of its members IDO, STAT3 and the AHR target gene CYP1B1 is associated with reduced relapse-free survival in lung cancer patients.

1 April 2015 in Cell Reports
Verified
Journal Article
Open access
VOValerie O'Leary
Valerie O'Leary
SOSaak Victor Ovsepian
Saak Victor Ovsepian
LCLaura Garcia Carrascosa
Laura Garcia Carrascosa
FBFabian Andreas Buske
Fabian Andreas Buske
VRVanja Radulovic
Vanja Radulovic
NANataša Anastasov
Nataša Anastasov
Exposure to low-dose irradiation causes transiently elevated expression of the long ncRNA PARTICLE (gene PARTICLE, promoter of MAT2A-antisense radiation-induced circulating lncRNA). PARTICLE affords both a cytosolic scaffold for the tumor suppressor methionine adenosyltransferase (MAT2A) and a nuclear genetic platform for transcriptional repression. In situ hybridization discloses that PARTICLE and MAT2A associate together following irradiation. Bromouridine tracing and presence in exosomes indicate intercellular transport, and this is supported by ex vivo data from radiotherapy-treated patients. Surface plasmon resonance indicates that PARTICLE forms a DNA-lncRNA triplex upstream of a MAT2A promoter CpG island. We show that PARTICLE represses MAT2A via methylation and demonstrate that the radiation-induced PARTICLE interacts with the transcription-repressive complex proteins G9a and SUZ12 (subunit of PRC2). The interplay of PARTICLE with MAT2A implicates this lncRNA in intercellular communication and as a recruitment platform for gene-silencing machineries through triplex formation in response to irradiation.

17 July 2020 in Cancer Immunology, Immunotherapy
Verified
Journal Article
Closed access
PDF file
XBXuanwen Bao
Xuanwen Bao
RSRun Shi
Run Shi
TZTianyu Zhao
Tianyu Zhao
YWYanfang Wang
Yanfang Wang
NANataša Anastasov
Nataša Anastasov
WFWeijia Fang
Weijia Fang

1 January 2017 in Mutation Research - Reviews in Mutation Research
Verified
Journal Article
Closed access
JHJanet Hall
Janet Hall
PJPenny A. Jeggo
Penny A. Jeggo
CWCatharine Mary Louise West
Catharine Mary Louise West
MGMaria Gomolka
Maria Gomolka
RQRoel Quintens
Roel Quintens
ECElisabeth Cardis
Elisabeth Cardis

29 September 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
LMLisa Mutschelknaus
Lisa Mutschelknaus
Omid AzimzadehOmid Azimzadeh
Omid Azimzadeh
THTheresa Heider
Theresa Heider
KWKlaudia Winkler
Klaudia Winkler
MVMarcus Vetter
Marcus Vetter
SMSimone Moertl
Simone Moertl
Radiation is a highly efficient therapy in squamous head and neck carcinoma (HNSCC) treatment. However, local recurrence and metastasis are common complications. Recent evidence shows that cancer-cell-derived exosomes modify tumour cell movement and metastasis. In this study, we link radiation-induced changes of exosomes to their ability to promote migration of recipient HNSCC cells. We demonstrate that exosomes isolated from irradiated donor cells boost the motility of the HNSCC cells BHY and FaDu. Molecular data identified enhanced AKT-signalling, manifested through increased phospho-mTOR, phospho-rpS6 and MMP2/9 protease activity, as underlying mechanism. AKT-inhibition blocked the pro-migratory action, suggesting AKT-signalling as key player in exosome-mediated migration. Proteomic analysis of exosomes isolated from irradiated and non-irradiated BHY donor cells identified 39 up- and 36 downregulated proteins. In line with the observed pro-migratory effect of exosomes isolated from irradiated cells protein function analysis assigned the deregulated exosomal proteins to cell motility and AKT-signalling. Together, our findings demonstrate that exosomes derived from irradiated HNSCC cells confer a migratory phenotype to recipient cancer cells. This is possibly due to radiation-regulated exosomal proteins that increase AKT-signalling. We conclude that exosomes may act as driver of HNSCC progression during radiotherapy and are therefore attractive targets to improve radiation therapy strategies.